Login

Friále invest in start-ups all over the world|Bryan Frist,Managing Partner,Friale 00:10:00

Share On Facebook Share On Twitter

Bryan Frist is the Founder & Managing Partner of Friále.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Harcourt’s Strategy-Focused Fund of Hedge Funds Outperforms with Precision Manager Selection and Unmatched Fee Efficiency|Ilario Scasascia,ED,Vontobel Asset Management AG
00:10:00
Antipa: Expanding Gold and Copper Resources in Western Australia
00:00:00
Shield Therapeutics talks extension of cash runway following US$10 million financing - Greg Madison Chief Executive Officer, Shield Therapeutics P
00:10:00
Nighthawk Gold Highlights Potential at One-to-One Conference
00:10:00
Semper Fortis Esports PLC CEO Kevin Soltani on First Day of Dealings and Fundraising Success | Kevin Soltani, CEO, Semper Fortis Esports PLC.
00:10:00
Navigating Market Chaos: Strategic Steps for Investors | Michael J. Evans - Founder of Cogent Strategic Wealth
00:10:00
Alex Kimber on Building Client-Focused Careers at Lord Abbett
00:10:00
Fireside Chat with Harfang Exploration: Merger, Exploration Plans, and Strategy
00:10:00
Legacy Financial Strategies: Expert Wealth Management for Seniors Since 1970 | Dave gner, Founder, Legacy Financial Strategies, Inc.
00:10:00
Unlocking Creativity: DMG Mori Harnesses Creo and Windchill Power | Alfred Geißler - CEO of DMG Mori AG
00:10:00
QED invests in businesses that disrupt and empower|Nigel Morris, Managing Partner,QED Investors
00:10:00
Balancing Government Dependency and Development | Roger Waesche Jr., CEO, Corporate Office Properties Trust.

© 2017 - Neuhu+